Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| NYSE | USD | Real-time | ||
| Mexico | MXN | Delayed | ||
| Stockholm | SEK | Real-time | ||
| NSE | INR | Real-time | ||
| BSE | INR | Delayed | ||
| Hamburg | EUR | Delayed | ||
| Xetra | EUR | Delayed | ||
| Frankfurt | EUR | Delayed | ||
| TradeGate | EUR | Delayed | ||
| Santiago | USD | Delayed | ||
| Buenos Aires | ARS | Delayed | ||
| BM&FBovespa | BRL | Delayed | ||
| Vienna | EUR | Delayed | ||
| Moscow | RUB | Real-time | ||
| KASE | KZT | Delayed | ||
| Lima | USD | Delayed |
By Carl O'Donnell and Jarrett Renshaw (Reuters) - Top U.S. health officials urged Americans to get vaccinated against COVID-19 on Wednesday, saying U.S. regulators' pause on...
Jeff Zients said the FDA's recommended pause on J&J's vaccine would not have a "significant impact" on the administration's vaccination program.
By Geoffrey Smith Investing.com -- U.S. stock markets opened higher on Wednesday after strong earnings from Goldman Sachs (NYSE:GS) and signs of economic recovery implicit in...
Yesterday, the US Food and Drug Administration halted the use of Johnson & Johnson's (NYSE:JNJ) one-shot coronavirus vaccine when a rare blood-clotting disorder developed in...
US inflation duly rose by 0.50% MoM for March overnight, roughly an eight-year high. However, the print was only just above expectations, and with markets ignoring the collapse of...
The price is rightStronger-than-expected US CPI report for March triggered lower UST yields, a rally in equities, and broad-based USD weakness. The data hurdle for a renewed leg...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Buy | Strong Buy | Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 328.28 | 429.54 | 310.00 | +78.28 | +31.31% | 79.89M | NASDAQ | |||
| 166.53 | 174.09 | 143.00 | +25.54 | +18.11% | 21.07M | NYSE | |||
| 69.60 | 71.20 | 68.98 | +0.30 | +0.43% | 4.95M | NASDAQ | |||
| 23.70 | 26.20 | 23.65 | -1.72 | -6.77% | 108.17M | NYSE | |||
| 42.97 | 50.98 | 42.26 | -8.030 | -15.75% | 42.50M | NASDAQ | |||
| 2,254.84 | 2,277.99 | 2,249.19 | -12.43 | -0.55% | 1.01M | NASDAQ | |||
| 16.19 | 16.89 | 16.16 | -0.69 | -4.09% | 3.67M | NYSE | |||
| 6.425 | 6.82 | 6.40 | -0.465 | -6.75% | 17.92M | NASDAQ | |||
| 7.16 | 7.33 | 7.12 | -0.18 | -2.45% | 8.58M | NYSE | |||
| 120.84 | 122.43 | 120.50 | -0.43 | -0.35% | 9.45M | NYSE | |||
| 134.75 | 137.84 | 133.91 | -2.55 | -1.86% | 9.96M | NASDAQ | |||
| 239.23 | 245.09 | 238.65 | -2.66 | -1.10% | 12.37M | NYSE | |||
| 9.99 | 10.02 | 9.96 | -0.02 | -0.20% | 442.52K | NYSE | |||
| 37.05 | 37.67 | 32.37 | +4.58 | +14.11% | 529.33K | NASDAQ | |||
| 50.16 | 61.55 | 49.30 | -9.100 | -15.36% | 52.50M | NASDAQ |
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.